FindTrial
Sign In

Role of biomarkers in diabetes

Role of specific inflammatory markers and adipokines in relation to insulin resistance and β-cell function.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012528
Enrollment
144
Registered
2018-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Lifestyle modification: Thrice weekly text messages to motivate participants to follow healthy lifestyle changes Messages are based on improvements in diet and physical activity Contr

Sponsors

India Diabetes Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both Men and women with no history of diabetes Persons with 3 or more of the following risk factors for diabetes a Age 35 to 55 years b Positive family history of diabetes c Body mass index greater than 23kg per m2 d Waist circumference more than 90cm for men and more than 80cm for women e Hypertension f Sedentary habits Persons with prediabetes having HbA1c values between 6 percent and less than 6 point 5 percent

Exclusion criteria

Exclusion criteria: Known diabetes Any other illness Unwilling to participate

Design outcomes

Primary

MeasureTime frame
Differences between baseline levels of visfatin resistin chemerin and fetuinA in cases developing T2DM and in normoglycaemiaTimepoint: 24 months—

Secondary

MeasureTime frame
Effect of lifestyle factors on study parameters Association of visfatin resistin chemerin and fetuinA with insulin resistance and β-cell function. Timepoint: 12 and 24 months—

Countries

India

Contacts

Public ContactMary Josephine Priscilla

India Diabetes Research Foundation

pris.mj14@gmail.com04428414311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026